XML 93 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Loss - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Net operating revenues (see Note 1) $ 3,286,000,000 $ 3,246,000,000 $ 3,302,000,000 $ 3,376,000,000 $ 3,453,000,000 $ 3,451,000,000 $ 3,562,000,000 $ 3,689,000,000 $ 13,210,000,000 [1] $ 14,155,000,000 [1] $ 15,353,000,000
Operating costs and expenses:                      
Salaries and benefits                 5,947,000,000 6,384,000,000 7,376,000,000
Supplies                 2,151,000,000 2,355,000,000 2,672,000,000
Other operating expenses                 3,303,000,000 3,496,000,000 3,864,000,000
Government and other legal settlements and related costs                 93,000,000 11,000,000 (31,000,000)
Electronic health records incentive reimbursement                 (1,000,000) (4,000,000) (28,000,000)
Lease cost and rent                 321,000,000 337,000,000 394,000,000
Depreciation and amortization                 608,000,000 700,000,000 861,000,000
Impairment and loss on sale of businesses, net                 138,000,000 668,000,000 2,123,000,000
Total operating costs and expenses                 12,560,000,000 13,947,000,000 17,231,000,000
Income from operations                 650,000,000 208,000,000 (1,878,000,000)
Interest expense, net of interest income of $3, $7, and $11 in 2019, 2018 and 2017, respectively                 1,041,000,000 976,000,000 931,000,000
Loss (gain) from early extinguishment of debt                 54,000,000 (31,000,000) 40,000,000
Equity in earnings of unconsolidated affiliates                 (15,000,000) (22,000,000) (16,000,000)
Loss from continuing operations before income taxes (115,000,000) (72,000,000) (149,000,000) (94,000,000) (369,000,000) (204,000,000) (129,000,000) (13,000,000) (430,000,000) [1] (715,000,000) [1] (2,833,000,000)
Provision for (benefit from) income taxes                 160,000,000 (11,000,000) (449,000,000)
Loss from continuing operations (346,000,000) 2,000,000 (146,000,000) (101,000,000) (299,000,000) (308,000,000) (91,000,000) (6,000,000) (590,000,000) [1] (704,000,000) [1] (2,384,000,000)
Discontinued operations, net of taxes:                      
Loss from operations of entities sold or held for sale                     (6,000,000)
Impairment of hospitals sold or held for sale                 0 0 (6,000,000)
Loss from discontinued operations, net of taxes                     (12,000,000)
Net loss                 (590,000,000) (704,000,000) (2,396,000,000)
Less: Net income attributable to noncontrolling interests                 85,000,000 84,000,000 63,000,000
Net loss attributable to Community Health Systems, Inc. stockholders $ (373,000,000) $ (17,000,000) $ (167,000,000) $ (118,000,000) $ (328,000,000) $ (325,000,000) $ (110,000,000) $ (25,000,000) $ (675,000,000) [1] $ (788,000,000) [1] $ (2,459,000,000)
Loss per share attributable to Community Health Systems, Inc. common stockholders:                      
Basic $ (3.27) [2] $ (0.15) [2] $ (1.47) [2] $ (1.04) [2] $ (2.91) [2] $ (2.88) [2] $ (0.97) [2] $ (0.22) [2] $ (5.93) [1],[2] $ (6.99) [1],[2] $ (22.00)
Diluted (3.27) (0.15) (1.47) (1.04) (2.91) (2.88) (0.97) (0.22) (5.93) [1] (6.99) [1] (22.00)
Basic loss per share attributable to Community Health Systems, Inc. common stockholders:                      
Continuing operations (3.27) [2] (0.15) [2] (1.47) [2] (1.04) [2] (2.91) [2] (2.88) [2] (0.97) [2] (0.22) [2] (5.93) [1],[2] (6.99) [1],[2] (21.89)
Discontinued operations                     (0.11)
Diluted loss per share attributable to Community Health Systems, Inc. common stockholders:                      
Continuing operations $ (3.27) $ (0.15) $ (1.47) $ (1.04) $ (2.91) $ (2.88) $ (0.97) $ (0.22) $ (5.93) [1] $ (6.99) [1] (21.89)
Discontinued operations                     $ (0.11)
Weighted-average number of shares outstanding:                      
Basic 113,935,629 113,891,721 113,862,097 113,257,608 112,909,869 112,865,482 112,837,944 112,291,496 113,739,046 [1] 112,728,274 [1] 111,769,821
Diluted 113,935,629 113,891,721 113,862,097 113,257,608 112,909,869 112,865,482 112,837,944 112,291,496 113,739,046 [1] 112,728,274 [1] 111,769,821
Operating Revenues (Net of Contractual Allowances and Discounts) [Member]                      
Net operating revenues (see Note 1)                     $ 18,398,000,000
Provision for Bad Debts [Member]                      
Net operating revenues (see Note 1)                     $ 3,045,000,000
[1] Total quarterly amounts may not add due to rounding.
[2] Total per share amounts may not add due to rounding.